Reminder: ViralClear to Host Conference Call and Webcast on September 22, 2020 to Discuss Phase 2 Human Trial of AntiViral Merimepodib Oral Solution for Treatment of COVID-19

September 21, 2020

BioSig Releases PURE EP Study Abstract with Data Presented at European Society of Cardiology’s ‘ESC Congress 2020’

September 15, 2020

BioSig Announces Abstract Acceptance to Computing in Cardiology 2020

September 14, 2020

Reminder: BioSig to Host Conference Call and Webcast on September 15, 2020 to Discuss Unblinding of PURE EP Human Data

September 14, 2020

ViralClear to Host Conference Call on September 22, 2020, to Discuss Phase 2 Human Trial of AntiViral Merimepodib Oral Solution for Treatment of COVID-19

September 9, 2020

BioSig to Host Conference Call on September 15, 2020 to Discuss Unblinding of PURE EP Human Data

September 2, 2020

BioSig Technologies to Present at The LD 500 Virtual Conference

August 25, 2020

Infectious Diseases Expert Prof. Angus Dalgleish Joins ViralClear’s Scientific Advisory Board

August 6, 2020

ViralClear Appoints Dr. Michael Sofia to Its Scientific Advisory Board

August 5, 2020

BioSig Installs PURE EP(tm) System at Massachusetts General Hospital

August 4, 2020